Recent Updates
Recently added Catalysts
RDY Positive Sentiment Score: 70/100

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.co

Key Takeaway: Dr. Reddy's Laboratories Ltd. has announced the allotment of 29,790 equity shares of Rs. 5 each to its employees following the exercise of their stock options. This decision, approved by the Nomination, Governance and Compensation Committee, will take effect on August 7, 2024. The shares will be issued under the Dr. Reddy's Employees ADR Stock Option Scheme, 2007, and align with regulatory requirements set forth by the SEBI. Overall, this move underscores the company's commitment to employee benefits and engagement.

Market Sentiment Analysis

POSITIVE FACTORS

  • Approval for the allotment of equity shares to employees indicates confidence in workforce motivation.
  • The shares rank equally with existing ones, ensuring value for both new and existing holders.
  • The exercise of stock options reflects positive employee engagement and retention strategy.

Full Press Release Details

National Stock Exchange of India Ltd. (Scrip
BSE Ltd. (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code:
NSE IFSC Ltd. (Stock Code: DRREDDY)
This is to inform you
that the Nomination, Governance and Compensation Committee of the Board of Directors of the Company has approved the allotment of 29,790
equity shares of Rs. 5/- each of the Company, fully paid up, on August 07, 2024, to employees pursuant to exercise of their Stock Options,
as per the following details:
Further, please find
enclosed the details as required under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Laboratories Limited
Company Secretary, Compliance Officer
Details under Regulation
10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
1 Company name and address of Registered Office: Dr. Reddy's Laboratories Limited 8-2-337, Road No.3, Banjara Hills, Hyderabad - 500034
2 Name of the Stock Exchanges on which the company's shares are listed: BSE Limited National Stock Exchange of India Limited New York Stock Exchange Inc. (ADRs) NSE IFSC Limited (ADRs)
3 Filing date of the statement referred in Regulation 10(b) of the SEBI (Share Based Employee Benefits) Regulations, 2021 with Stock Exchange: The Schemes were institutionalised under the erstwhile the SEBI (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999 and appropriate details under Schedule V were filed. The Schemes comply with provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
4 Filing Number, if any: NA
5 Title of the Scheme pursuant to which shares are issued, if any: Dr. Reddy's Employees ADR Stock Option Scheme, 2007
6 Kind of security to be listed: Equity Shares
7 Par value of the shares: Rs. 5/-
8 Date of issue of shares: August 07, 2024 (Date of allotment on exercise)
9 Number of shares issued: 29,790 equity shares
10 Share Certificate No., if applicable: NA
11 Distinctive number of the share, if applicable: 213232506 to 213262295
12 ISIN Number of the shares if issued in Demat: INE089A01023
13 Exercise price per share: 1. 10,820 equity shares exercised at Rs.5/- per share 2. 16,435 equity shares exercised at Rs. 3,679/- per share 3. 2,535 equity shares exercised at Rs. 5,301/- per share
14 Premium per share: a) 10,820 equity shares- Nil b) 16,435 equity shares- Rs. 3,674/- per share c) 2,535 equity shares - Rs. 5,296/- per share
15 Total Issued shares after this issue: 16,68,59,691 (*)
16 Total Issued share capital after this issue: Rs. 83,42,98,455/-
17 Details of any lock-in on the shares: NA
18 Date of expiry of lock-in: NA
19 Whether shares identical in all respects to existing shares if not, when will they become identical? Yes, the shares rank pari passu with the existing shares
20 Details of listing fees, if payable: NA
paid up capital after this issue: 16,68,59,491, i.e., Rs. 83,42,97,455 (difference of 200 due to forfeited shares of Rs. 5/- each in
September 1988 on account of non-payment of allotment money.)

Frequently Asked Questions

What company approved the allotment of equity shares?

Dr. Reddy's Laboratories Limited approved the allotment.

How many shares were allotted on August 07, 2024?

A total of 29,790 equity shares were allotted.

What is the par value of the issued shares?

The par value of the shares is Rs. 5/- each.

Are the new shares identical to existing shares?

Yes, the new shares rank pari passu with existing shares.

What is the exercise price for share options?

Exercise prices vary from Rs. 5/- to Rs. 5,301/- per share.

Last updated: Aug 7, 2024